While there’s no cure for multiple sclerosis (MS), there are many treatments ... According to one research review, mesenchymal stem cell (MSC) therapy may help reduce or prevent central nervous ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

B-cell therapy is an important treatment option for RRMS. Ask your doctor these questions to decide if you could benefit from B-cell therapy.

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying ...

Therapeutic monoclonal antibodies (mAbs) are potent new tools for a molecular targeted approach to modify the course of multiple sclerosis ... rationales for MS therapy, putative modes of action ...

Widespread and irreversible axonal pathology has been shown to occur at the earliest stages of the multiple sclerosis (MS ... is a strong argument for early therapy, and several randomized ...

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator.

Doctors may recommend oral or infused steroid therapy for severe multiple sclerosis flare-ups that impact your functioning. Treatment with steroids can cause side effects. If you have multiple ...

Findings show accumulation of neuronal injury and functional decline suggesting that changes in gonadal hormones may be associated with changes in functional and biological markers in MS.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing the symptoms is increasingly important to get treatment early.

B-cell therapy for MS is effective, but it can be expensive. Here’s where to turn if you need help paying for - cell therapy.